## Laurus Labs Limited (LAURUSLABS) Stock Analysis - 20-Dec-2024

This report analyzes Laurus Labs Limited (LAURUSLABS) stock based on the provided data.  The analysis focuses solely on the provided data and does not consider external market factors or sentiment.

**1. Data Preprocessing:**

The provided data has been parsed and organized into the following sections:

**1.1 Company Profile:**

| Feature          | Value                     |
|-----------------|--------------------------|
| Symbol           | LAURUSLABS                |
| Company Name     | Laurus Labs Limited        |
| Industry         | Pharmaceuticals           |
| Listing Date     | 2016-12-19                |
| ISIN             | INE947Q01028              |


**1.2 Market Data (20-Dec-2024):**

| Metric                | Value      |
|-----------------------|-------------|
| Last Price            | 558.50     |
| Change                | -14.05     |
| % Change              | -2.45%     |
| Previous Close        | 572.55     |
| Open                  | 572.80     |
| Close                 | 559.20     |
| VWAP                  | 565.18     |
| Week High             | 593.00     |
| Week Low              | 360.85     |
| Sector PE             | 236.69     |
| Symbol PE             | 236.69     |
| Total Traded Volume   | 1,286,282  |
| Delivery Quantity     | 690,830   |
| Delivery %            | 53.71%     |
| CM Daily Volatility   | 1.95       |
| CM Annual Volatility  | 37.25      |


**1.3 Pre-Open Market Data (20-Dec-2024):**

The pre-open market shows a slightly lower price (572.80) compared to the previous close (572.55), indicating a slightly negative sentiment at the start of the trading day.  However, the final pre-open price is higher than the closing price.

**1.4 Corporate Actions:**

| Ex-Date      | Purpose                               |
|--------------|---------------------------------------|
| 06-Nov-2024  | Interim Dividend - Rs 0.40 Per Share |
| 04-Jul-2024  | Annual General Meeting                |
| 08-May-2024  | Interim Dividend - Re 0.40 Per Share  |
| ...          | ...                                   |  *(Further historical data available)*


**1.5 Recent Announcements:**

| Broadcast Date | Subject                                      |
|-----------------|----------------------------------------------|
| 20-Dec-2024    | General Updates                             |
| 06-Dec-2024    | Press Release                                |
| 06-Dec-2024    | General Updates                             |
| ...            | ...                                          | *(Further historical data available)*


**1.6 Financial Results (Last Five Quarters):**

| Quarter      | Income (₹'000) | Expenditure (₹'000) | Profit After Tax (₹'000) | EPS (₹) |
|--------------|-----------------|-----------------------|--------------------------|---------|
| Q2 FY25      | 119,674         | 113,865               | 4,244                     | 0.79    |
| Q1 FY25      | 112,623         | 108,743               | 2,878                     | 0.53    |
| Q4 FY24      | 143,861         | 127,430               | 12,132                    | 2.25    |
| Q3 FY24      | 114,291         | 108,621               | 4,264                     | 0.79    |
| Q2 FY24      | 116,393         | 110,072               | 4,667                     | 0.87    |


**1.7 Shareholding Patterns:**

| Date         | Promoter & Promoter Group (%) | Public (%) |
|--------------|-----------------------------|------------|
| 30-Sep-2023  | 27.20                         | 72.80      |
| 31-Dec-2023  | 27.19                         | 72.81      |
| 31-Mar-2024  | 27.19                         | 72.81      |
| 30-Jun-2024  | 27.18                         | 72.82      |
| 30-Sep-2024  | 27.18                         | 72.82      |

Promoter holdings have shown a very slight decrease over the past year.


**1.8 Board Meetings:**

*(Dates and purposes of board meetings are available in the data but not included here for brevity.  They primarily relate to the approval of financial results and dividend announcements.)*


**1.9 Key Management Personnel:**

*(List of directors and their designations are available in the data but not included here for brevity.)*


**2. Key Indicators:**

**2.1 Current Price Analysis:**

* The current price (558.50) is significantly lower than the week's high (593.00) and the previous close (572.55), indicating a recent downward trend.
* The week's low (360.85) suggests considerable volatility.


**2.2 Financial Performance:**

* Revenue has been relatively stable over the last five quarters, with some fluctuation.
* Profit after tax shows some variability, with a significant increase in Q4 FY24.
* EPS also shows variability, with a high in Q4 FY24.  The recent quarters show lower EPS.


**2.3 Shareholding Analysis:**

* Promoter holdings have decreased slightly over the past year, but remain relatively stable.  This is not a significant negative indicator.


**2.4 Corporate Action Summary:**

* Regular interim dividends have been paid, indicating a commitment to shareholder returns.


**2.5 Volatility and Risk:**

* The stock exhibits considerable volatility, as evidenced by the week's high and low, and the CM Annual Volatility.


**3. Final Verdict:**

**Hold.**

**Reasoning:**

While the recent price action shows a downward trend and the stock exhibits high volatility, the financial results, although variable, show profitability in all reported quarters.  The consistent payment of dividends is a positive sign. The slight decrease in promoter holdings is not alarming.  More data is needed to determine if the recent price drop is a temporary correction or the start of a longer-term decline.  Given the current information, a "Hold" recommendation is the most prudent course of action.  Further monitoring of the company's performance and market conditions is advised before considering a buy or sell decision.

**Conclusion:**

Based on the provided data, Laurus Labs Limited presents a mixed picture. While the recent price decline and volatility are concerning, the company's profitability and dividend payments suggest underlying strength.  A "Hold" verdict is recommended pending further observation and analysis.  Additional data points, such as future financial results and market trends, would be beneficial for a more definitive assessment.
